Purchases and Sales Made in Q3 2023 in Enlivex Therapeutics Ltd. (ENLV)
This table provides information about the institutional ownership of Enlivex Therapeutics Ltd. (ENLV) during Q3 2023. The information is specifically focused on institutions that hold shares of Enlivex Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
2.2K+ 3.88% |
$3.21K - $6.53K
|
58.9K
$64.2K
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
305+ 0.7% |
$445 - $906
|
44.2K
$48.1K
|
|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
1New |
$1.46 - $2.97
|
1
$1.09
|
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-932- 2.41% |
$1.36K - $2.77K
|
37.7K
$41.1K
|
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.18K- 49.56% |
$1.72K - $3.5K
|
1.2K
$1.31K
|
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group Ltd.
Dublin, L2 |
SELL
|
- |
-2.77K- 18.32% |
$4.04K - $8.21K
|
12.3K
$13.4K
|
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
SELL
|
- |
-17.1K- 96.13% |
$25K - $50.8K
|
690
$752
|